Microsoft word - s._rashid_publications

Shirya Rashid PEER-REVIEWED PUBLICATIONS

1. CORTÉS VA, CURTIS DE, SUKUMARAN S,. SHAO X, RASHID S, SMITH AR, REN J,
HAMME RE, AGARWAL AK, HORTON JD, GARG A. MOLECULAR MECHANISMS OF
HEPATIC STEATOSIS AND INSULIN RESISTANCE IN THE AGPAT2-DEFICIENT MOUSE
MODEL OF CONGENITAL GENERALIZED LIPODYSTROPHY. (CELL METABOLISM, 9:165-
176, 2009).
2. RASHID S, MARCIL M, RUEL I, AND GENEST J. IDENTIFICATION OF A NOVEL LIPID
EFFLUX DEFECT CAUSING LOW HDL CHOLESTEROL THAT IS NOT DUE TO MUTATIONS
IN THE ABCA1 GENE BUT TO REGULATION OF ABCA1 PROTEIN. (SUBMITTED TO
EUROPEAN HEART JOURNAL).
3. RASHID S, ANDERSON NN, HO YK, HAMMER RE, MOON YA AND HORTON JD. THE IN
VIVO EFFECTS OF CONDITIONAL GENE DELETION OF SREBP-2. (IN PREPARATION).
4. RASHID S AND FRANCIS G. STATINS AND PRIMARY PREVENTION: IS ALL THE
EVIDENCE IN? CANADIAN JOURNAL OF CARDIOLOGY, 24(4): 301-303, 2008.
5. RASHID S AND GENEST J. THE EFFECT OF OBESITY ON HDL METABOLISM. OBESITY
RESEARCH, 15(12): 2875-2888, 2007. 6. RASHID S AND KHANDAKER NR. RISK FACTORS FOR EARLY MYOCARDIAL
INFARCTION IN SOUTH ASIANS. JAMA, 297(17): 1880-1881, 2007.
7. RASHID S. SHOULD CHOLESTEROL-LOWERING MEDICATION BE AVAILABLE WITHOUT
A PRESCRIPTION IN CANADA? CANADIAN JOURNAL OF CARDIOLOGY , 23(3): 189-
193, 2007.
8. RASHID S, PATTERSON B AND LEWIS G. WHAT HAVE WE LEARNED ABOUT HDL
METABOLISM FROM KINETIC STUDIES IN HUMANS? JOURNAL OF LIPID RESEARCH,
47(8): 1631-42, 2006.
9. KRIMBOU L, HASSAN HH, BLAIN S, RASHID S, DENIS M, MARCIL M AND GENEST J.
BIOGENESIS AND SPECIATION OF NASCENT APOA-I-CONTAINING PARTICLES IN
VARIOUS CELL LINES. JOURNAL OF LIPID RESEARCH, 46: 1668-1677, 2005.
10. RASHID S, CURTIS DE, GARUTI R, ANDERSON NN, BASHMAKOV Y, HO YK, HAMMER
RE, MOON YA AND HORTON JD. DECREASED PLASMA CHOLESTEROL AND
HYPERSENSITIVITY TO STATINS IN MICE LACKING PCSK9. PROCEEDINGS OF THE
NATIONAL ACADEMY OF SCIENCES, 102(15), 2005.
11. RASHID S AND LEWIS, GF. THE MECHANISMS OF DIFFERENTIAL
MINERALOCORTICOID AND GLUCOCORTICOID ACTION IN THE BRAIN AND PERIPHERAL
TISSUES. CLINICAL BIOCHEMISTRY, 38: 401-09, 2005.
12. RASHID S, WATANABE T, SAKAUE T AND LEWIS GF. MECHANISMS OF HDL
LOWERING IN INSULIN-RESISTANT, HYPERTRIGLYCERIDEMIC STATES: THE
COMBINED EFFECT OF HDL TRIGLYCERIDE-ENRICHMENT AND ELEVATED HEPATIC
LIPASE ACTIVITY. CLINICAL BIOCHEMISTRY , 36(6): 421-29, 2003.
13. RASHID S, TRINH DK, UFFELMAN KD, COHN, JS, RADER DJ AND LEWIS GF.
EXPRESSION OF HUMAN HEPATIC LIPASE IN THE RABBIT MODEL PREFERENTIALLY
ENHANCES THE CLEARANCE OF TRIGLYCERIDE ENRICHED VERSUS NATIVE HDL
APOLIPOPROTEIN A-I. CIRCULATION, 107(24): 3066-72, 2003.
14. RASHID S, BARRETT PHR, UFFELMAN KD, WATANABE T, ADELI K, AND LEWIS GF.
LIPOLYSIS OF TRIGLYCERIDE-ENRICHED HDL BY HEPATIC LIPASE EX-VIVO
ENHANCES HDL APOLIPOPROTEIN A-I CLEARANCE IN A RABBIT MODEL.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 22(3):483-7, 2002.
15. RASHID S, UFFELMAN KD, BARRETT PHR, AND LEWIS GF. THE EFFECT OF
ATORVASTATIN ON HDL APOLIPOPROTEIN A-I PRODUCTION AND CLEARANCE IN THE
NEW ZEALAND WHITE RABBIT. CIRCULATION, 106(23): 2955-60, 2002.
16. RASHID S, UFFELMAN KD, AND LEWIS GF. THE MECHANISM OF HDL LOWERING IN
HYPERTRIGLYCERIDEMIC, INSULIN RESISTANT STATES. JOURNAL OF DIABETES AND
ITS COMPLICATIONS, 16(1):24-8, 2002.
17. RASHID S, UFFELMAN KD, BARRETT PHR, VICINI P, ADELI K, AND LEWIS
GF.TRIGLYCERIDE ENRICHMENT OF HDL DOES NOT ALTER HDL-SELECTIVE
CHOLESTERYL ESTER CLEARANCE IN RABBITS. JOURNAL OF LIPID RESEARCH ,
42(2):265-71, 2001.
18. LEWIS GF, RASHID S, AND LAMARCHE B. MECHANISM OF HDL LOWERING IN INSULIN
RESISTANT STATES. ADV EXP MED BIOL, 498:273-7, 2001.
19. RASHID S, SHI Z.Q, NIWA M, MATHOO JMR, VAN DELANGERYT M, BILINSKI D, LEWIS
GF, AND VRANIC M. BETA-BLOCKADE, BUT NOT NORMOGLYCEMIA NOR
HYPERINSULINEMIA, MARKEDLY DIMINISHES STRESS-INDUCED HYPERGLYCEMIA IN
DIABETIC DOGS. DIABETES , 49(2):253-62, 2000.
20. LAMARCHE, B, RASHID S, AND LEWIS G.F. HDL METABOLISM IN
HYPERTRIGLYCERIDEMIC STATES: AN OVERVIEW. CLIINICA CHIMICA ACTA. 286(1-
2):145-61, 1999.
21. SADHU H, WIESENTHAL SR, MACDONALD PE, MCCALL RH, TCHIPASHVILI V, RASHID S, SATKUNARAJAH M, IRWIN DM, SHI ZQ, BRUBAKER, PL., WHEELER MB,
VRANIC M, EFENDIC S. AND GIACCA A. GLUCAGON-LIKE PEPTIDE 1 INCREASES
INSULIN SENSITIVITY IN DEPANCREATIZED DOGS. DIABETES 48(5):1045-53, 1999.
22. NIWA M, RASHID S, SHUM K, MATHOO J, TCHIPAHVILI V, MATHOO J, CHAN O,
KAWAMORI R, VRANIC M, AND GIACCA A. THE EFFECT OF JTT501 ON HEPATIC AND
PERIPHERAL GLUCOSE UPTAKE IN ALLOXAN-INDUCED DIABETIC DOGS.
METABOLISM 49(7): 862-7, 2000.

PUBLICATIONS IN SUPPLEMENTS

23. RASHID S, RUEL I, MARCIL M AND GENEST J. IDENTIFICATION OF A NOVEL LIPID
EFFLUX DEFECT CAUSING LOW HDL CHOLESTEROL THAT IS NOT DUE TO
MUTATIONS IN THE ABCA1 GENE BUT TO REGULATION OF ABCA1 PROTEIN.
CIRCULATION 116 (SUPPL.II) (16): 1179, 2007.
24. RASHID S, RUEL I, ALRASSADI K, DASTANI Z, MARCIL M AND GENEST J. CELLULAR
PHYSIOLOGY OF CHOLESTEROL EFFLUX DEFECTS IN LOW HDL-C INDIVIDUALS WITH
A NORMAL ABCA1 GENE. CIRCULATION 114 (SUPPL. II) (18): 1347, 2006.
25. DENIS M, HASSAN HH, RASHID S, KRIMBOU AND GENEST J. FORMATION OF A
PRODUCTION COMPLEX BETWEEN APOLIPOPROTEIN A-I AND THE ATP-BINDING
CASSETTE TRANSPORTER A1 IS ESSENTIAL FOR INTRACELLULAR LIPIDATION OF
APOA-I. CIRCULATION 112 (SUPPL. S) (17): U158 584, 2005.
26. RASHID S, TRINH D, UFFELMAN K, RADER D, LEWIS GF. EXPRESSION OF HUMAN
HEPATIC LIPASE IN THE RABBIT MODEL PREFERENTIALLY ENHANCES THE
CLEARANCE OF TRIGLYCERIDE-ENRICHED VERSUS NATIVE HDL APOLIPOPROTEIN A-
I. DIABETES 52 (SUPPL. 1): A73, 2003.
27. NIWA M, RASHID S, SHUM K, MATHOO J, TCHIPACHVILI V, CHAN O, KAWAMORI R,
VRANIC M, GIACCA A. JTT-501 INCREASES HEPATIC AND PERIPHERAL GLUCOSE
UPTAKE AND SUPPRESSES GLUCOSE PRODUCTION IN ALLOXAN-INDUCED DIABETIC
DOGS. DIABETES 47 (SUPPL. 1):A94, 1998.
28. SANDHU H, WIESENTHAL S, MCCALL R, TCHIPACHVILI V, RASHID S, VRANIC M,
EFENDIC S, GIACCA A. GLUCAGON-LIKE PEPTIDE 1 (GLP-1) INCREASES INSULIN
SENSITIVITY IN DIABETIC DOGS. DIABETES 46 (SUPPL. 1): 29A, 1997.
29. RASHID S, NIWA M, VANDELANGERYT M, MATHOO J, BILINSKI D, SHI Q, VRANIC M.
THE IMPAIRMENT OF THE GLUCOREGULATORY RESPONSES TO STRESS IN DIABETES.
DIABETES 46 (SUPPL. 1); 230A, 1997.

NON-PEER-REVIEWED PUBLICATIONS

30. RASHID S AND LEWIS GF. THE CONTRIBUTIONS OF TRIGLYCERIDE ENRICHMENT OF
HDL AND LIPOLYSIS OF HDL BY HEPATIC LIPASE IN THE PATHOPHYSIOLOGICAL
LOWERING OF HDL CONCENTRATIONS IN HYPERTRIGLYCERIDEMIC STATES.
INTERNATIONAL ATHEROSCLEROSIS WEBSITE, 2002.

Source: http://www.taari.ca/files/rashidpublications.pdf